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Background: Cancer survivorship in Ireland is increasing in both frequency and longevity. However, a significant proportion
of cancer survivors do not reach the recommended physical activity levels and have overweight. This has implications for both
physical and psychological health, including an increased risk of subsequent and secondary cancers. Mobile health (mHealth)
interventions demonstrate potential for positive health behavior change, but there is little evidence for the efficacy of mobile
technology in improving health outcomes in cancer survivors with overweight or obesity.
Objective: This study aims to investigate whether a personalized mHealth behavior change intervention improves physical and
psychological health outcomes in cancer survivors with overweight or obesity.
Methods: A sample of 123 cancer survivors (BMI≥25 kg/m2) was randomly assigned to the standard care control (n=61) or
intervention (n=62) condition. Group allocation was unblinded. The intervention group attended a 4-hour tailored lifestyle
education and information session with physiotherapists, a dietician, and a clinical psychologist to support self-management of
health behavior. Over the following 12 weeks, participants engaged in personalized goal setting to incrementally increase physical
activity (with feedback and review of goals through SMS text messaging contact with the research team). Direct measures of
physical activity were collected using a Fitbit accelerometer. Data on anthropometric, functional exercise capacity, dietary
behavior, and psychological measures were collected at face-to-face assessments in a single hospital site at baseline (T0), 12
weeks (T1; intervention end), and 24 weeks (T2; follow-up).
Results: The rate of attrition was 21% (13/61) for the control condition and 14% (9/62) for the intervention condition. Using
intent-to-treat analysis, significant reductions in BMI (F2,242=4.149; P=.02; ηp
2=0.033) and waist circumference (F2,242=3.342;
P=.04; ηp2=0.027) were observed in the intervention group. Over the 24-week study, BMI was reduced by 0.52 in the intervention
condition, relative to a nonsignificant reduction of 0.11 in the control arm. Waist circumference was reduced by 3.02 cm in the
intervention condition relative to 1.82 cm in the control condition. Physical activity level was significantly higher in the intervention
group on 8 of the 12 weeks of the intervention phase and on 5 of the 12 weeks of the follow-up period, accounting for up to 2500
additional steps per day (mean 2032, SD 270).
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Conclusions: The results demonstrate that for cancer survivors with a BMI≥25 kg/m2, lifestyle education and personalized goal
setting using mobile technology can yield significant changes in clinically relevant health indicators. Further research is needed
to elucidate the mechanisms of behavior change and explore the capacity for mHealth interventions to improve broader health
and well-being outcomes in the growing population of cancer survivors.
Trial Registration: ISRCTN Registry ISRCTN18676721; https://www.isrctn.com/ISRCTN18676721
International Registered Report Identifier (IRRID): RR2-10.2196/13214
(JMIR Mhealth Uhealth 2021;9(7):e24915) doi: 10.2196/24915
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There is an average of 35,000 new cases of cancer diagnosed
each year in Ireland, representing a doubling of cases in the past
25 years [1]. At the same time, cancer survivorship in Ireland
is also increasing, with survival at 5 years from diagnosis having
increased from 42% in 1994 to 62% in 2019, with cancer
survivors now making up 4% of the Irish population [1].
There is consistent evidence of a positive association between
overweight, obesity, and all-cause morbidity and mortality [2].
A high BMI, poor diet, and lack of physical activity are
identifiable risk factors for cancer development, and in cancer
survivors, these factors can increase the risk of a secondary
cancer or a subsequent primary cancer [3,4]. Cancer and its
treatment can result in fatigue, physical inactivity, and loss of
muscular strength [5]. Approximately 50% of cancer survivors
have overweight or obesity [6], and research has linked obesity
to a 46% increased risk of developing distant metastases in
women [7]. Considering the consequences of morbidity and
mortality, there is a need to facilitate rehabilitation of cancer
survivors to reduce BMI, improve diet, and increase physical
activity.
Health behavior change interventions can improve physical
health outcomes, such as weight and BMI, as well as health
behavior (eg, physical activity) and psychological health (eg,
quality of life and well-being) in both the general population
[8] and among cancer survivors [9,10]. The use of mobile
technology (eg, apps and wearables) has been associated with
significant reductions in weight and BMI [11] and significant
increases in physical activity [12,13]. Mobile health (mHealth)
interventions may be able to meet the need for cost-effective
health behavior change interventions that can be incorporated
into oncology services. Although mHealth interventions hold
significant potential, adopting a theory- and evidence-based
approach to intervention design is critical [14]. The behavior
change wheel is a synthesis of 19 frameworks of behavior
change [15]. The behavior change wheel, together with the
behavior change technique (BCT) taxonomy, a standardized
list of the active ingredients of behavior change interventions
[16], enables researchers to develop and describe complex
interventions in a systematic and rigorous manner.
Systematic review evidence suggests that the use of relevant
BCTs significantly increased the success of weight loss
programs [17]. A systematic review of existing healthy eating
and physical activity interventions identified the BCTs
self-monitoring in combination with goal setting and feedback
as the most effective [18]. Furthermore, a meta-analysis of 30
randomized controlled trials (RCTs) that focused on increasing
physical activity among cancer survivors reported that the BCTs
prompts, social rewards, and graded tasks were associated with
larger increases in physical activity in this population [19].
Consequently, these BCTs should be considered for inclusion
in interventions aimed at increasing healthy eating and physical
activity behaviors among cancer survivors.
Studies have found that both mHealth tools and relevant BCTs
can lead to positive health behavior changes and weight loss;
therefore, the delivery of BCTs through mHealth tools may be
particularly effective. Digital interventions that included a
greater number of BCTs were found to have larger effects on
health behavior change than interventions with fewer BCTs
[20]. A review and meta-analysis of studies using activity
monitors found that in people with obesity, physical activity
increases were greatest when the BCTs goal setting and feedback
were incorporated in the mHealth intervention [21]. A systematic
content analysis of the BCTs provided by wearable activity
monitors concluded that most activity monitors included
self-monitoring, goal setting, and feedback [22]. Incidentally,
a review by Michie et al [18] found these to be the most effective
BCTs for promoting healthy diet and physical activity overall.
mHealth interventions incorporating relevant BCTs have the
potential to improve health and well-being outcomes. However,
there are a limited number of mHealth interventions for cancer
survivors that describe content in terms of BCTs. A recent
systematic review identified 15 digital health behavior change
interventions for cancer survivors, concluding that digital
interventions may improve physical activity and reduce BMI;
however, findings regarding dietary behavior and well-being
outcomes are mixed [23]. Although many of the included studies
were pilot or feasibility trials, they highlighted the potential for
mHealth interventions to improve health behavior and health
outcomes among cancer survivors. All but one study included
in this review relied on self-report measures of physical activity
[24]. Self-report measures have known limitations, such as recall
bias; misinterpretation of items; and overestimation of activity
relative to direct measures, such as accelerometer devices
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[25-28]. Relative to accelerometers, error rates between 35%
and 79% have been observed on self-report measures [29,30].
Furthermore, it is noteworthy that only two of the included
digital interventions purposively sampled cancer survivors with
overweight or obesity [31,32]. This population is arguably most
in need of intervention, and health behavior change interventions
using nondigital mode of delivery (MOD) can improve outcomes
for this cohort of survivors [33,34]. Overall, there is a need for
more large-scale RCTs to provide high-quality evidence
regarding the impact of mHealth interventions on objectively
measured outcomes in cancer survivors with overweight or
obesity.
Aims and Objectives
The aim of this study is to investigate the impact of a
personalized mHealth behavior change intervention on physical
and psychological health outcomes in a group of cancer
survivors with overweight or obesity. More specifically, this
project examined the impact of lifestyle education and
personalized goal setting, compared with standard medical care,
on physical activity (step count) as well as other behavioral,
clinical, and psychological outcomes.
Methods
Overview
The full methodological details of the trial, including a detailed
description of the development of the intervention, are reported
in the study protocol [35] and are summarized below. We used
the eHealth extension of the CONSORT (Consolidated
Standards of Reporting Trials) statement when writing this paper
[36].
Trial Design
A 2-arm, parallel, open-label RCT design was used to investigate
the impact of the intervention versus standard care on clinical,
psychological, and health behavior outcomes.
Sample Size
The statistical program G*Power was used to conduct power
analysis. With 2 groups (intervention and control), 3
measurements (baseline, time 1, and time 2), an assumed
correlation among repeated measures of 0.3, a small-medium
effect size, and a power of 0.8, the recommended sample size
for repeated measures analysis of variance (ANOVA) was 102.
A final sample size of 123 was calculated based on an attrition
rate of 20%, as observed in similar studies using mobile
technology interventions with cancer survivors [37].
Randomization
Participants were randomized to either the intervention or the
standard care control condition using a computerized random
number generator (enrollment was carried out by MGK and JR,
and randomization and group allocation was carried out by JG).
The study was not blinded, but step count, one of the main
outcome measures, was recorded directly using the Fitbit device
(Healthy Metrics Research, Inc).
Study Setting
Recruitment took place offline (by phone), and assessments
were carried out face-to-face in a single hospital site,
Letterkenny University Hospital, County Donegal, Ireland.
Assessments were performed before randomization (T0;
baseline), at 12 weeks (T1; intervention end), and at 24 weeks
(T2; follow-up).
Ethics Approval
The design of this study was approved by the Research Ethics
Committee of the National University of Ireland, Galway, on
September 12, 2017 (Ref: 17/MAY/20) and by the Research
Ethics Committee at Letterkenny University Hospital on May
2, 2017.
Inclusion Criteria
Adults aged 18-70 years, with a calculated BMI≥25 kg/m2, with
a solid cancer and who had completed active cancer treatment
(those continuing on endocrine therapy were permitted
inclusion), who attended Oncology Services in Letterkenny
University Hospital during the recruitment phase (December
2017 to January 2018), and who were willing to use mobile
technology were eligible to participate.
Recruitment
Participants were recruited from the Oncology Services of
Letterkenny University Hospital. A total of 159 eligible
participants (aged 18-70 years, BMI≥25, and active cancer
treatment completed) were identified sequentially from the
oncology outpatient waiting list (N=347) by the clinical team.
The clinical team contacted these participants by telephone,
described the aims and design of the study, and asked if they
were willing to use mobile technology. Prospective participants
who expressed interest in the study were sent a participant
information sheet and consent form (Multimedia Appendix 1).
Informed written consent was provided by 77.3% (123/159;
response rate) of participants, who then underwent in-person
baseline assessments. Of the 36 eligible participants who did
not consent to participate (36/159, 22.6%), 28 (78%) were not
interested, 3 (8%) were waiting for surgery, 1 (3%) had chronic
obstructive pulmonary disease, 1 (3%) was undergoing
recurrence workup, 2 (6%) had young children, and 1 (3%) did
not drive (Figure 1). A total of 10 eligible participants who were
willing to use mobile technology but did not own a smartphone
were provided with an Amazon Fire 7 tablet.
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Figure 1. CONSORT (Consolidated Standards of Reporting Trials) diagram showing the flow of participants through each stage of the randomized
controlled trial.
Intervention
This complex intervention was delivered through mHealth
technology and included BCTs that aimed to improve clinical,
psychological, and health behavior outcomes. The full details
are described in the study protocol [35]. In summary, the
intervention consisted of 2 components:
1. A 4-hour lifestyle education and information session (week
1) was delivered by health care professionals (3
physiotherapists, 1 dietician, and 1 clinical psychologist).
Physiotherapists demonstrated a series of daily
strengthening exercises and recommended schedules for
moderate-intensity physical activity. The dietician delivered
a comprehensive overview on healthy eating; answered
numerous questions that clarified misinformation on
nutrition; and specifically advised participants to reduce
their caloric intake and reduce the intake of red meat,
processed meat, salt, and sugar and increase fruit, vegetable,
and fiber intake. The clinical psychologist offered practical
strategies for problem solving, identifying barriers to
change, and preventing relapse. The BCTs included in this
session and the corresponding code from the BCT
Taxonomy V1 [16] were goal setting (outcome) (1.3),
provide information on consequences of behavior to the
individual (5.1), demonstration of the behavior (6.1),
provide instruction on how to perform the behavior (4.1),
problem solving (1.2), goal setting (behavior) (1.1), and
action planning (1.4). These BCTs were applied to both
physical activity and dietary behavior changes. The MOD
for this component of the intervention was face-to-face
human contact in real time with groups of participants.
During this session, all participants were provided with a
Fitbit Alta.
2. An 8-week goal-setting intervention (weeks 4-12) was
delivered using mobile technology (ie, Fitbit Alta
accelerometer plus SMS text messaging contact).
Participants received weekly text messages with feedback
on their average daily step count and a goal of increasing
their step count by 10% in the following week. The BCTs
included in the personalized goal-setting intervention were
self-monitoring of behavior (2.3), feedback on behavior
(2.2), goal setting (behavior) (1.1), graded tasks (8.7),
social reward (10.4), and review behavior goal(s) (1.5).
The MOD for this intervention component was human
contact at a distance using nonautomated SMS text
messages facilitated using digital wearable technology (ie,
Fitbit Alta). Participants continued to wear the Fitbit for
the remainder of the study (24 weeks), but the personalized
goal-setting intervention ceased at 12 weeks.
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Participants randomized to the control condition received
standard care and were also provided with a Fitbit Flex 2 to
measure physical activity for the 24 weeks of the study. As
such, a number of BCTs were also present in the control
condition in this study. On being enrolled in the study for
meeting eligibility criteria (BMI≥25 kg/m2), all participants
were encouraged to maintain a healthy weight (goal setting
[outcome; 1.3]). Fitbit accelerometers were distributed at a
15-minute group meeting, where provision of health information
was available in the form of leaflets (information on
consequences of behavior to the individual [5.1] but not BCT
instruction on how to perform the behavior [4.1] or
demonstration of the behavior [6.1]). In contrast to the Fitbit
Alta distributed to the intervention group, the display panel on
the Fitbit Flex 2 does not present summary data (ie, step count),
and the app dashboard was modified to not display summary
data on the participants’ mobile device. The visual display on
the device and the app was limited but did not eliminate
self-monitoring of behavior(2.3) in the control condition. A
comparison of the BCTs included in the intervention and control
conditions of the study is presented in Textbox 1.
Textbox 1. A comparison of the behavior change techniques included in the intervention and control conditions.
Intervention (Behavior Change Technique, Corresponding Code From the Taxonomy: and Definition):
• Goal setting (outcome; 1.3): “set or agree on a goal defined in terms of a positive outcome of the wanted behavior.”
• Provide information on the consequences of behavior to the individual (5.1): “provide information (eg, written, verbal, and visual) about health
consequences of performing the behavior.”
• Demonstration of the behavior (6.1): “provide an observable sample of the performance of the behavior.”
• Provide instruction on how to perform the behavior (4.1): “advise or agree on how to perform the behavior.”
• Problem solving (1.2): “analyze, or prompt the person to analyze, factors influencing the behavior and generate or select strategies that include
overcoming barriers and/or increasing facilitators.”
• Goal setting (behavior; 1.1): “set or agree on a goal defined in terms of the behavior to be achieved.”
• Action planning (1.4): “prompt detailed planning of performance of the behavior, must include at least one of context, frequency, duration, and
intensity.”
• Self-monitoring of behavior (2.3): “establish a method for the person to monitor and record their behavior(s) as part of a behavior change strategy.”
• Feedback on behavior (2.2): “monitor and provide informative or evaluative feedback on performance of the behavior and must include one of
form, frequency, duration, and intensity.”
• Goal setting (behavior; 1.1): “set or agree on a goal defined in terms of the behavior to be achieved.”
• Graded tasks (8.7): “set easy-to-perform tasks, making them increasingly difficult, but achievable, until behavior is performed.”
• Social reward (10.4): “arrange verbal or nonverbal reward if and only if there has been effort and/or progress in performing the behavior (includes
positive reinforcement).”
• Review behavior goal(s) (1.5): “review behavior goal(s) jointly with the person and consider modifying the goal(s) or behavior change strategy
in light of achievement.”
Control (Behavior Change Technique, Corresponding Code From the Taxonomy: and Definition):
• Goal setting (outcome) (1.3): “set or agree on a goal defined in terms of a positive outcome of the wanted behavior.”
• Provide information on consequences of behavior to the individual (5.1): “provide information (eg, written, verbal, and visual) about health
consequences of performing the behavior.”
• Self-monitoring of behavior (2.3): “establish a method for the person to monitor and record their behavior(s) as part of a behavior change strategy.”
Materials
All participants were provided with a Fitbit activity tracker for
the duration of the study. Each participant was registered with
a Fitbit user account. Accounts were set up using a centralized
email address corresponding to their study ID number and a
randomly generated alphanumeric password. The Fitbit was set
up and paired with the participants’ mobile devices (ie,
smartphone or tablet). The participants were also given an
information sheet with instructions on how to synchronize their
Fitbit device and app and asked to perform this weekly to
prevent loss of data. This sheet also contained the contact details
of the research team should they encounter any technical issues
or wish to discuss any concerns with their health care providers.
A computer program was developed by the Insight Centre for
Data Analytics at the National University of Ireland, Galway,
to allow participants’physical activity data to be extracted from
the Fitbit server. A member of the research team (JG) logged
in to each participant’s user account and authorized this
third-party program to access their data from Fitbit. The
anonymized data for all participants were exported to Excel for
analysis.
Fixes
To facilitate the goal-setting intervention, a weighted average
for daily step count was calculated for participants with at least
five observations per week. Participants who showed no activity
for more than 2 days a week were contacted to verify that there
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were no technical issues. There were a number of possible
reasons for someone to have 0 steps on a given day (eg, the
participant did not wear the monitor or the Fitbit failed to
record). These reasons were not recorded, and self-reported
adherence to monitor wear was not measured. Within 2 weeks
of receipt, a number of participants reported challenges using
their Fitbit. As a result, all participants were invited to attend 1
of the 2 technical support sessions. A total of 12 participants
attended a session and received hands-on support and
troubleshooting advice regarding their device from the research
team (JG and MGK). Following the implementation of the
European Union General Data Protection Regulation (May
2018), participants were automatically logged out of their Fitbit
app. However, this was possible to fix at a distance over the




Anthropometric measurements included weight in kilograms,
BMI, and waist circumference in centimeters.
Functional Exercise Capacity
The 6-minute walk test measures the distance walked in 6
minutes on a hard, flat surface. Systolic blood pressure, diastolic
blood pressure, heart rate, blood oxygen saturation, subjective
fatigue, and dyspnea were measured pretest (ie, resting), posttest,
and 4 minutes later (ie, recovery).
Psychological Outcomes
Health-related quality of life was measured using the Medical
Outcomes Survey Short Form (RAND-36) [38]. Other measures
of psychological well-being outcomes include the 3-item
Loneliness Scale [39], the Brief Fatigue Inventory [40], and the
General Self-Efficacy Scale [41]. Exercise self-efficacy [42]
and social support for physical activity [43] were also measured.
Health Behavior Outcomes
Self-reported physical activity was measured using the Godin
Leisure-Time Exercise Questionnaire [44], and physical activity
level (ie, average daily step count) was measured directly using
the Fitbit activity tracker. Dietary data were collected using the
European Prospective Investigation into Cancer and Nutrition
Norfolk Food Frequency Questionnaire [45].
All outcomes were measured at baseline (T0), 12 weeks (T1;
intervention end), and 24 weeks (T2; follow-up). The measures
are described in full in the trial protocol [35].
Statistical Methods
Missing Data
To maximize power and conform to intent-to-treat analysis,
missing data were handled using the expectation-maximization
(EM) algorithm. A nonsignificant MCAR test [46] showed that
the data were missing completely at random (χ230,080=113.3
P=.99); therefore, data substitution methods were deemed
appropriate. For step count data specifically, EM data
substitution was applied only to the 107 participants who
received a Fitbit. The 16 participants in the intent-to-treat group
(ie, those who could not attend the initial session where Fitbits
were distributed) were not included in the missing value analysis
and EM data substitution for the analyses of group differences
in step count.
Analysis
A series of 3 (time: baseline [T0], 12 weeks [T1], and 24 weeks
[T2])×2 (group: control and intervention) mixed ANOVAs were
performed to determine the effect of the intervention on clinical,
psychological, and health behavior outcomes. In the case of a
significant interaction effect, follow-up two-tailed independent
sample t tests were conducted to investigate between-group
differences at each time point, and one-way ANOVAs were
conducted to identify within-group differences across time
points. Independent samples t tests were used to analyze group
differences (control and intervention) in average daily step count
across the 24 weeks of the study.
Results
Participant Flow
A flow diagram of the progress through each phase of this
2-group parallel randomized trial is shown in Figure 1. A total
of 123 eligible participants underwent baseline assessments.
The participants were then randomized to the control or
intervention arm. Of the 123 participants, 62 (50.4%) were
assigned to the intervention group and were invited to attend a
lifestyle education and information session where they would
also receive their Fitbit activity monitor, and out of these, 55
(89%) participants were able to attend the session. The
remaining 61 participants assigned to the control group were
invited to an appointment where they were provided with a
Fitbit activity monitor, and out of these, 53 (87%) participants
were able to attend the session. All participants were invited to
a postintervention assessment (12 weeks later) to determine the
impact of the lifestyle education and information session and
personalized goal-setting mHealth intervention on improving
clinical, psychological, and health behavior outcomes. A total
of 55 participants in the intervention condition and 52
participants in the control condition attended the assessment.
Finally, to determine whether any effects of the intervention
were maintained 3 months later, all participants were invited to
a follow-up assessment (24 weeks after baseline assessment).
In total, 53 participants in the intervention group and 48
participants in the control group attended the follow-up
assessment. This resulted in an overall attrition rate of 21%
(13/61) in the control arm and 14% (9/62) in the intervention
arm.
Baseline Data
Participants’ characteristics are described in Table 1.
Randomization resulted in an intervention group that was
younger, had lower weight and BMI, and had a higher number
of males.
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Table 1. Participants’ characteristics at baseline assessment (N=123).
Intervention (n=62)Control (n=61)Characteristics
55.61 (8.05)59.24 (7.65)Age (years), mean (SD)
84.18 (13.98)87.10 (16.32)Weight (kg), mean (SD)










Have you ever been told by a doctor that you have or have had any of the following conditions? n (%)
2 (4)1 (2)Angina
1 (2)3 (6)Heart attack
18 (33)19 (36)High blood pressure
1 (2)3 (6)Stroke
6 (11)5 (9)Diabetes





Means and SDs for all anthropometric measurements are
presented in Table 2.
Table 2. Anthropometric measurements.























30.47 (3.74)82.59 (13.69)82.11 (13.41)84.17 (13.11)Intervention
aT0: time 0 (baseline).
bT1: time 1 (intervention end; 12 weeks).
cT2: time 2 (follow-up; 24 weeks).
Weight
There was no significant interaction effect on weight
(F2,242=2.615; P=.07). A main effect of time was observed
(F2,242=18.14; P<.001; ηp
2=0.13). There was no main effect of
group (F1,121=1.786; P=.18).
BMI
There was a significant interaction between group and time
(F2,242=4.149; P=.02; ηp
2=0.033) as shown in Figure 2.
Follow-up t tests revealed significant group differences in BMI
at baseline (t121=2.451; P=.02), at 12 weeks (t121=3.018;
P=.003), and at 24 weeks (t121=2.876; P=.005). There was a
significant change in BMI across time points in the intervention
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group (F2,122=12.513; P<.001; ηp
2=0.17). BMI was significantly
lower at both 12 weeks (mean difference [MD] −0.689; P<.001)
and 24 weeks (MD −0.520; P=.007) than at baseline. In the
control group, there was a nonsignificant reduction in BMI
(F2,120=1.041; P=.36) at 12 weeks (MD −0.18) and 24 weeks
(MD 0.11).
Figure 2. Results of 3×2 mixed analysis of variance showing a significant reduction in BMI for the intervention group only. T0: time 1, baseline; T1:
time 1, intervention end (12 weeks); T2: time 2, follow-up (24 weeks).
Waist Circumference
There was a significant interaction effect for waist circumference
(F2,242=3.342; P=.04; ηp
2=0.027) shown in Figure 3. Post hoc
analysis revealed a significant change in waist circumference
across time points in both the intervention group (F2,122=29.632;
P<.001; ηp2=0.327) and the control group (F2,120=20.08;
P<.001; ηp2=0.251). In the intervention group, waist
circumference was significantly lower at both 12 weeks (MD
−2.725; P<.001) and 24 weeks (MD −3.019; P<.001) than at
baseline. This trend was also observed in the control group,
with waist circumference significantly lower at both 12 weeks
(MD −1.535; P<.001) and at 24 weeks (MD −1.822; P<.001)
than at baseline. However, the magnitude of change was greater
in the intervention group than in the control group (MD −1.19,
SD 0.56; 95% CI −2.31 to −0.06; t121=2.091; P=.04). The
difference in waist circumference between 12 and 24 weeks
was not significant in the intervention group (MD −0.294;
P=.17) or the control group (MD −0.286; P=.21).
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Figure 3. Results of 3×2 mixed analysis of variance showing a significant reduction in waist circumference that was maintained at follow-up in both
conditions, with a larger reduction in the intervention group. T0: time 1, baseline; T1: time 1, intervention end (12 weeks); T2: time 2, follow-up (24
weeks).
Functional Exercise Capacity
There was no significant interaction effect for distance walked;
systolic blood pressure; diastolic blood pressure; heart rate;
subjective fatigue; or dyspnea measured before, after, or 3
minutes after the 6-minute walk test (the full set of results are
presented in Multimedia Appendix 2). In short, the main effects
of time showed that both the groups significantly improved
from baseline to T2 in 13 measures of functional exercise
capacity (all P<.001), and the means and SDs are presented in
Table 3.
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Table 3. Measures of the 6-minute walk test.
Intervention, mean (SD)Control, mean (SD)Outcomes
T2T1T0T2cT1bT0a
590.28 (87.78)571.72 (61.68)532.57 (69.8)566.29 (71.79)551.25 (62.44)515.99 (67.9)Distance walked
139.99 (33.52)129.97 (16.27)139.95 (21.04)139.45 (13.24)135.3 (16.16)144.12 (19.57)Resting SBPd
152.97 (38.02)145.1 (21.07)151.67 (23.43)150.66 (17.33)151.03 (19.18)154.48 (20.83)Posttest SBP
132.81 (19.19)129.38 (15.96)138.01 (18.2)135.08 (14.74)134.31 (17.25)142.32 (17.66)Recovery SBP
77.54 (11.06)76.11 (9.12)79.56 (9.79)80.67 (8.25)76.76 (9.2)80.89 (7.86)Resting DBPe
80.28 (10.83)77.39 (10.75)81.27 (12.45)81.89 (11.66)81.78 (12.17)82.15 (8.94)Posttest DBP
78.28 (9.74)76.35 (9.32)78.83 (10.62)78.31 (7.45)77.54 (9)80.27 (8.06)Recovery DBP
74.09 (13.30)77.56 (15.17)78.73 (11.4)77.4 (9.27)77.36 (8.56)79.01 (10.28)Resting HRf
113.53 (50.21)105.89 (24.44)127.06 (143.76)113.45 (17.61)103.51 (17.94)111.67 (17.39)Posttest HR
83.02 (15.57)82.31 (12.45)85.13 (13.32)83.5 (10.75)82.07 (10.77)85.49 (11.88)Recovery HR
6.05 (1.39)6.17 (1.03)6.35 (0.79)5.96 (1.06)6.22 (0.91)6.39 (0.9)Resting fatigue
10.2 (3.19)10.54 (2.45)9.9 (2.41)10.35 (2.72)10.73 (1.98)9.83 (2.36)Posttest fatigue
6.08 (2.71)6.56 (1.38)6.88 (1.23)6.09 (1.42)6.4 (0.98)6.93 (1.6)Recovery fatigue
1.35 (0.97)1.15 (0.67)1.19 (0.65)1.58 (1.19)1.12 (0.42)1.24 (0.73)Resting dyspnea
4.25 (2.4)4.04 (1.75)3.5 (1.33)5.06 (4.61)3.74 (1.47)4.02 (1.67)Posttest dyspnea
1.45 (1.51)1.40 (0.87)1.64 (0.94)1.88 (1.88)1.24 (0.47)1.81 (0.97)Recovery dyspnea
aT0: time 0 (baseline).
bT1: time 1 (intervention end; 12 weeks).
cT2: time 2 (follow-up; 24 weeks).
dSBP: systolic blood pressure.




No significant interaction effects were observed for
health-related quality of life (measured by the RAND36 Medical
Outcomes Survey). Means and SDs are presented in Table 4,
and the results of the ANOVA are presented in Multimedia
Appendix 3.
Table 4. Subscales of RAND-36 Medical Outcomes Survey.
Intervention, mean (SD)Control, mean (SD)Outcome
T2T1T0T2cT1bT0a
77.66 (19.83)80.08 (17.28)73.87 (20.33)81.15 (17.28)81.81 (14.52)77.87 (17.06)Physical functioning
79.03 (33.63)85.89 (30.57)69.76 (37.64)77.05 (35.15)78.28 (29.39)69.67 (39.82)Role limitations: physical health
83.33 (31.22)87.37 (29.37)72.58 (40.72)83.06 (32.56)89.62 (23.99)83.06 (33.12)Role limitations: emotional health
75.57 (21.52)79.28 (19.62)73.47 (23.16)74.22 (23.63)78.11 (21.65)73.24 (21.85)Pain
78.77 (18.04)79.87 (16.32)73.03 (18.66)83.74 (13.28)81.77 (13.59)77.38 (17.57)Emotional well-being
85.88 (20.69)89.31 (17.8)78.63 (23.01)88.31 (18.8)91.8 (15.79)78.48 (23.4)Social functioning
63.06 (18.07)67.02 (17.15)53.39 (21.27)68.69 (19.68)70.99 (16.38)61.39 (20.21)Energy
53.04 (15.74)56.98 (12.94)49.5 (16.54)55.87 (16.4)57.6 (15.87)51.73 (20.17)General health
aT0: time 0 (baseline).
bT1: time 1 (intervention end; 12 weeks).
cT2: time 2 (follow-up; 24 weeks).
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There were also no significant interaction effects for loneliness,
self-efficacy, exercise self-efficacy, or exercise social support
(full results, including nonsignificant findings, are presented in
Multimedia Appendix 4). The means and SDs are presented in
Table 5.
Table 5. Psychological outcome measures.
Intervention, mean (SD)Control, mean (SD)Outcomes
T2T1T0T2cT1bT0a
3.74 (1.01)3.69 (0.9)3.63 (1.02)4.34 (1.63)4.1 (1.57)4.23 (1.64)Loneliness
21.49 (15.95)20 (16.45)23.36 (19.42)31.05 (20.3)25.18 (20.79)35.47 (20.47)Fatigue (global)
6.90 (3.47)6.38 (3.55)6.92 (3.89)8.9 (4.59)8.05 (4.88)9.77 (4.92)Fatigue severity
11.48 (10.99)10.53 (11.33)13.1 (13.47)17.76 (14.21)13.28 (14.64)20.63 (14.43)Fatigue interference
22.01 (4.02)22.16 (3.92)21.69 (4.19)21.96 (4.62)22.27 (4.26)20.56 (4.45)Self-efficacy
22.41 (3.63)22.69 (3.85)23.14 (2.49)21.08 (4.98)21.93 (4.56)22.33 (4.14)Exercise: self-efficacy
12.1 (5.01)13.03 (4.31)12.33 (4.92)12.45 (4.8)13.39 (4.39)12.36 (5.39)Exercise: social support
aT0: time 0 (baseline).
bT1: time 1 (intervention end; 12 weeks).
cT2: time 2 (follow-up; 24 weeks).
Fatigue
As shown in Figure 4, there was a significant interaction
between groups and time (F2,242=3.199; P=.04; ηp
2=0.026).
Independent samples t tests revealed significant differences
between the intervention and control groups at baseline
(t121=3.365; P=.001) and at 24 weeks (t121=2.908; P=.004) but
not at 12 weeks (t121=1.534; P=.13). Fatigue remained stable
in the intervention group (F2,122=1.815; P=.17). The change in
global fatigue in the control group was significant
(F2,120=11.701; P<.001; ηp
2=0.163). Fatigue was significantly
lower at 12 weeks than at baseline (MD −10.289; P<.001) and
was significantly higher at 24 weeks than at 12 weeks (MD
5.872; P=.001). The difference in fatigue between baseline and
24 weeks was not significant (MD −4.417; P=.052).
Figure 4. Results of a 3×2 mixed analysis of variance showing a significant reduction in fatigue at 12 weeks and a nonsignificant increase at 24 weeks
in the control group only. T0: time 1, baseline; T1: time 1, intervention end (12 weeks); T2: time 2, follow-up (24 weeks).
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Dietary data were collected using the European Prospective
Investigation into Cancer and Nutrition Norfolk Food Frequency
Questionnaire 45. There were no significant interaction effects
for any of the 10 food groups assessed (Multimedia Appendix
5), and the means and SDs are presented in Table 6.
Table 6. Dietary behavior.
Intervention, mean (SD)Control, mean (SD)Outcomes
T2T1T0T2cT1bT0a
18.6 (6.18)17.45 (5.32)17.63 (6.62)16.64 (4.14)16.33 (4.78)16.25 (4.06)Fiber
1828.44 (687.56)1760.36 (569.79)2030.77 (664.09)1687.54 (455.96)1681.15 (562.66)1846.14 (538.65)Kilocalorie
2840.5 (1075.67)2586.32 (834.46)3131.63 (1021.24)2685.03 (759.71)2547.2 (785.47)2940.68 (891.54)Sodium
27.52 (15.98)24.80 (13.1)31.95 (14.17)26.30 (10.29)24.91 (10.35)29.06 (13.26)Saturated fats
312.33 (329.19)310.94 (214.98)259.69 (179.98)269.74 (160.84)291.02 (153.8)243.29 (138.28)Fruit
120.22 (59.21)106.49 (78.39)125.58 (62.87)119.18 (49.56)103.33 (48.28)126.40 (54.37)Meat
36.89 (36.42)31.09 (22.25)55.51 (57.16)35.55 (28.4)31.84 (28.06)48.65 (45.42)Sugar
303 (130.75)264.88 (106.22)248.9 (127.94)263.57 (105.37)244.62 (95.77)231.91 (101.65)Vegetables
3.28 (7.95)2.80 (7.23)3.62 (9.97)2.15 (2.6)1.75 (2.46)2.02 (2.67)Alcohol
40.67 (108.43)31.81 (91.21)44.97 (132.53)27.79 (39.86)20.67 (28.95)22.53 (27.63)Alcoholic beverages
aT0: time 0 (baseline).
bT1: time 1 (intervention end; 12 weeks).
cT2: time 2 (follow-up; 24 weeks).
Self-reported Physical Activity Level
There was no significant main effect of time (F2,242=1.56;
P=.21). There was no main effect of condition (F1,121=0.073;
P=.79) and no significant interaction effect (F2,242=0.260;
P=.77). The means and SDs are presented in Table 7.
Table 7. Scores on the Godin Leisure-Time Exercise Questionnaire.
Intervention, mean (SD)Control, mean (SD)Outcome
T2T1T0T2cT1bT0a
30.38 (16.71)34.75 (18.34)31.14 (20.52)33.03 (29.39)34.68 (26.12)31.03 (17.25)Weekly leisure activity
aT0: time 0 (baseline).
bT1: time 1 (intervention end; 12 weeks).
cT2: time 2 (follow-up; 24 weeks).
Direct Physical Activity Level
The step count data were collected continuously using Fitbit.
Daily step count totals were summed, and an average daily step
count was calculated for each week of the 24-week study. Means
and SDs are presented in Table 8, along with the results of
independent t tests comparing group differences in step count.
The intervention group had a significantly higher average daily
step count on 13 of the 24 weeks of the study (ie, weeks 3, 5-9,
11, 12, 14-17, and 21), contributing to an additional 1689-2500
steps per day (mean 2032, SD 270).
An analysis of the personalized goal-setting intervention
demonstrated that 69% (37/54) of participants in the intervention
group met at least 50% (4/8) of their step count goals. However,
the goal success rate was not significantly correlated with any
of the study outcome variables. A further analysis of prescribed
step count goals within the context of goal achievement indicates
that success was highest in the earlier stages of the goal-setting
intervention when step count goals were below 10,000 steps
(Table 9).
JMIR Mhealth Uhealth 2021 | vol. 9 | iss. 7 | e24915 | p. 12https://mhealth.jmir.org/2021/7/e24915
(page number not for citation purposes)
Walsh et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Table 8. Average daily step count for weeks 1-24 (N=107).
P valuet test (df)Intervention, mean (SD)Control, mean (SD)Group
.990.012 (105)8775.34 (8946.51)8792.11 (3990.17)Week 1
.59−0.542 (105)8978.65 (6063.41)8434.01 (4135.28)Week 2
.01−2.7 (105)10,401.04 (3659.81)8622.72 (3126.16)Week 3
.10−1.646 (105)9833.51 (3737.18)8638.9 (3768.52)Week 4 (SMS 1)
<.001−3.133 (105)10,621.07 (4020.28)8359.62 (3414.64)Week 5 (SMS 2)
.01−2.555 (105)10,265.19 (4345.32)8308.83 (3523.38)Week 6 (SMS 3)
<.001−3.122 (105)10,982.03 (4708.59)8519.34 (3318.01)Week 7 (SMS 4)
.02−2.319 (105)12,247.11 (5842.16)9940.19 (4317.15)Week 8 (SMS 5)
.03−2.263 (105)10,744.1 (4681.16)8819.53 (4088.03)Week 9 (SMS 6)
.15−1.438 (105)10,262.84 (4780.74)9065.88 (3755.52)Week 10 (SMS 7)
.03−2.225 (105)10,610.33 (5441.93)8576.29 (3865.43)Week 11 (SMS 8)
.03−2.196 (105)10,915.87 (4804.31)9067.76 (3838.9)Week 12
.19−2.113 (105)11,080.53 (5621.11)9883.54 (3462.85)Week 13
.04−2.06 (105)10,908.43 (4703.33)9219.04 (3711.7)Week 14
.01−2.474 (105)11,260.69 (4871.56)9185.22 (3715.93)Week 15
.04−2.116 (105)9553.78 (5119.87)7750.5 (3536.26)Week 16
.04−2.139 (105)10,513.67 (4666.4)8726.35 (3938.05)Week 17
.07−1.843 (105)10,255.48 (3446.08)9020.32 (3487.54)Week 18
.10−1.657 (105)10,901.42 (4965.92)9480.41 (3820.46)Week 19
.07−1.833 (105)10,108.47 (4817.34)8624.73 (3426.48)Week 20
<.001−2.883 (105)10,201.34 (4386.2)7700.75 (4584.27)Week 21
.16−1.4 (105)10,171.88 (7265.27)7520.26 (11826.73)Week 22
.22−1.228 (105)9481.54 (5442.37)8224.2 (5145.45)Week 23
.24−1.173 (105)9700.24 (5860.72)8483.63 (4808.37)Week 24


































Step count goal, mean (SD)
24 (44)17 (32)18 (33)35 (65)35 (65)25 (46)39 (72)41 (76)Did achieve goal, n (%)
30 (56)37 (68)36 (67)19 (35)19 (35)29 (54)15 (28)13 (24)Did not achieve goal, n (%)
Discussion
Principal Findings
The aim of this trial is to examine the impact of a personalized
mHealth behavior change intervention on clinical, psychological,
and health behavior outcomes among a group of cancer survivors
with overweight or obesity. The results show that the
intervention yielded several significant benefits over and above
that shown in the standard care control group. The intervention
group had a significantly greater reduction in BMI than the
control group. This reduction in BMI was maintained at the
24-week follow-up. Relative to the control group, there was a
significantly greater reduction in waist circumference in the
intervention group. At follow-up, there was a modest reduction
in BMI (0.52) and waist circumference (3.02 cm) with small to
medium effect sizes. In relation to behavioral outcomes,
participants in the intervention group had significantly higher
physical activity during both the intervention phase (8 out of
the 12 weeks) and the follow-up phase (5 out of the 12 weeks)
than those in the control group. Participants in the intervention
averaged approximately 2000 extra steps per day (the equivalent
of 1 mile or 20 minutes of physical activity [47]). However,
there were no significant changes in functional exercise capacity,
dietary behavior, or psychological outcomes.
The design of this intervention is aligned with the National
Institute for Health and Care Excellence guidelines for weight
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management in people with obesity [48]. They recommend
multicomponent interventions that include effective behavior
change strategies aimed at increasing physical activity or
decreasing sedentary behavior, reducing energy intake, and
improving diet quality. Although the statistically significant
changes in anthropometric measures observed in this study fall
short of the 5% change deemed clinically significant, the clinical
guidelines for obesity management acknowledge that more
modest losses can also yield significant health benefits [48].
The magnitude of change observed here is in line with the results
of traditional behavioral interventions for people with
overweight or obesity [49] and cancer [50]. They are also
consistent with interventions using digital MOD for people with
chronic conditions, such as obesity [51] and cancer [23]. Cancer
survivorship is characterized by ongoing physical and
psychological challenges, making behavior change and weight
management more difficult [52], and any change observed is
of paramount clinical importance for this population.
Furthermore, the results of a mixed methods investigation nested
within this RCT and published separately concluded that this
intervention is acceptable to participants [53], in addition to
being effective.
A key element of this intervention was the use of personalized
goals delivered through mobile technology (ie, Fitbit and SMS
text messaging contact). This aimed to enhance participants’
motivation to increase their overall levels of physical activity.
In addition to significant increases in physical activity (step
count), the results show a good level of goal achievement,
suggesting that goal-setting intervention did influence
participants’ motivation to increase activity. Although goals
were personalized (ie, increase daily step count by 10% per
week), goal attainment was highest in the initial stages when
step count targets were lower, suggesting there may be a
threshold after which increasing step count become unattainable.
This is not surprising, and recent evidence suggests that
significant health benefits are achievable at much lower levels
of physical activity (ie, 4400-7500 steps per day) [54]. This is
also in line with existing studies, which found that setting a
higher physical activity goal leads to higher physical activity
levels but concurrently lower goal achievement [55]. This
suggests that goal setting may be more effective in the early
stages of the physical activity intervention, but it becomes less
critical to attaining a higher physical activity level once a certain
threshold is consistently achieved or perhaps when health
behaviors have been consolidated. If one assumes that a low
level of goal achievement is deleterious over time (eg, decrease
in motivation) [56], the results do not rule out the existence of
an optimal goal-setting zone for some participants. This was
the approach taken in this study, where targets were based on
current performance. Swann et al [56] argued that achievement
of goals is actually not the primary aim of goal-setting theory;
instead, goal setting is simply a mechanism for enhancing task
performance regardless of whether the goal is achieved. Within
this context, a higher step count is a positive outcome, despite
failure to achieve step count targets at the higher end of the
spectrum. It is likely that this component of the intervention,
including the highly effective BCTs of goal setting, feedback,
review, and self-monitoring [17-19] delivered via mobile
technology, facilitated the higher levels of physical activity in
the intervention participants, thus contributing to the significant
reductions in BMI and waist circumference.
Although the results did not demonstrate any significant
improvements in dietary behavior, it is clear that changes in
lifestyle (primarily increased physical activity) contributed to
significantly greater benefits in key clinical outcomes for the
intervention group. An emerging body of research with cancer
survivors suggests that digital interventions have positive effects
on BMI and physical activity, but the findings are less consistent
for diet [23]. For example, the digital health behavior change
intervention by O’Carroll Bantum et al [57] also found increased
physical activity but no increase in fruit or vegetable intake
among cancer survivors. As such, the results of this study are
in line with those of previous studies. On reflection it is not
wholly unexpected that no significant dietary behavior changes
were found. Participants in the intervention group attended a
4-hour lifestyle education and information session that included
BCTs related to dietary behavior change delivered by a dietician,
in addition to a goal-setting intervention that focused exclusively
on physical activity. This may not have been sufficient to change
dietary behavior. In postintervention interviews, participants
indicated that additional behavioral support was needed to
change their diet [53]. The success of the goal-setting
intervention for increasing step count in this study is
encouraging, and future digital interventions should consider
goal setting in relation to dietary behavior in combination with
physical activity goals.
This intervention had 2 behavioral targets (increase physical
activity and improve diet) to improve health and well-being
outcomes. Systematic review evidence has found that health
behavior change interventions focusing on physical outcomes
improve well-being in the general population [8] and among
cancer survivors [9,10]. Therefore, it was unexpected that
despite increased physical activity levels, the intervention group
did not report significant improvements in any of the
psychological well-being outcomes over the course of the study.
These findings are consistent with other lifestyle interventions
for cancer survivors that also found no significant group
differences in quality of life [32,58,59], well-being [23], or
fatigue [20,60]. One possibility for the lack of significant effects
is the relatively high levels of well-being in participants at
baseline. Furthermore, although participants received a
comprehensive presentation from a clinical psychologist at the
lifestyle education and information session, this presentation
focused on behavior (eg, action planning and problem solving);
thus, there was no aspect of the intervention that deliberately
targeted increased well-being. Future interventions may wish
to incorporate techniques and strategies aimed at improving
well-being more directly. Nevertheless, qualitative data show
that participants perceived the aim of the intervention to be
moving on psychologically from cancer and reported emotional
and psychological improvements as a result of participating
[53]. These self-reported improvements did not translate into
statistically significant interaction effects in this trial.
Strengths and Limitations
Although the effect sizes were small to medium, the large
sample size and high retention rate means that the study was
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adequately powered to detect such effects. Participants were
randomized to conditions to reduce selection bias, and the use
of intention-to-treat analysis limited the impact of attrition bias.
However, it was not possible to blind participants or outcome
assessors in this study, a limitation common to many digital
health interventions [36]. This may have introduced a
performance or detection bias. Furthermore, the analyses were
not adjusted for baseline differences that occurred due to chance.
Unadjusted analyses from randomized trials provided valid
estimates of effects [61], and baseline levels of variables that
are likely to be prognostic (ie, anthropometric measures) were
accounted for in the analyses. Nevertheless, these results should
be interpreted with caution. The participants were mostly female
breast cancer survivors. This is representative of trends in the
wider literature [62] but may limit the generalizability of the
findings to people with other types of cancer and to people of
other genders in the wider population. Furthermore, inclusion
criteria required participants to be willing to use mobile
technology. This may have contributed to a digital divide, in
the sense that prospective participants who may have benefited
from the intervention were excluded because they were
inexperienced or uncomfortable using digital technologies. It
is worth noting that no one was excluded due to a lack of mobile
technology; participants who did not have access to but were
willing to engage with mobile technology were provided with
a mobile device (Amazon Fire tablet) by the research team.
Finally, the participants in the trial had access to technical
support from the research team, as needed. This was front
loaded, as support was needed more frequently at
commencement when participants were becoming familiar with
the technology. This may not be feasible in standard oncology
care, limiting the applicability of the findings outside of an RCT
setting. A custom-built front-end software was used to bulk
export participants’ step count data to facilitate the weekly
goal-setting intervention; as such, something similar may be
needed if applying the same intervention in a health care setting
[63]. Future research will be needed to identify potential
implementation issues for delivering this intervention in clinical
settings.
A notable strength of this study is the use of a direct measure
of physical activity (ie, Fitbit accelerometer). In a review of 15
digital health behavior change interventions with cancer
survivors [23], no study had used a direct measure of physical
activity to evaluate the impact of the intervention. The majority
of studies rely on self-report measures that are biased in a
number of ways and provide less accurate estimates than
accelerometers [25-28,30]. Consumer-based wearable
accelerometers offer similar accuracy to criterion measures in
controlled settings [64,65] and in free-living settings [66,67].
However, relative to research-grade accelerometers, some
studies have reported underestimation [68] and overestimation
of steps [69], especially at faster ambulatory speeds. In addition
to the high cost of these devices (eg, ActivPAL and ActiGraph),
there are a number of practical constraints to their use in studies
with large samples and over longer time frames [70,71]. To our
knowledge, no study has examined the potential differences in
precision between the 2 Fitbit models used in this study.
Reassuringly, the Fitbit has been consistently rated among the
most accurate consumer-based wearable activity monitor for
measuring step count [64,68,72]. According to the authors’
knowledge, this trial is the first to evaluate a digital health
behavior change intervention using a direct measure of physical
activity with a sample of cancer survivors with overweight or
obesity. That being said, self-report measures of dietary behavior
were used in this study, although interviews by health care
professionals (ie, 24-hour dietary recall) would have been
superior, particularly for accurately measuring caloric intake.
Conclusions
Cancer survivors who have overweight or obesity require
additional support to self-manage their health behaviors.
mHealth technology may provide a cost-effective solution within
modern oncology care. mHealth has enormous potential for
improved health care delivery, but evidence from this group
currently lacks a strong base [58,62]. The results of this study
represent a promising contribution to the field. This mHealth
intervention significantly reduced BMI and waist circumference
and increased physical activity levels, but it was consistent with
an emerging body of research with cancer survivors [23], which
demonstrates limited impact on diet or well-being. Future
research is needed to continue evaluating and refining mHealth
behavior change interventions to improve health and well-being
outcomes for the growing number of cancer survivors.
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